Used in targeted cancer therapy, particularly in ovarian and other AMHR2-expressing tumors. Binds selectively to AMHR2 receptors on cancer cells, enabling precise delivery of cytotoxic agents or immune-mediated destruction. Investigated in antibody-drug conjugates (ADCs) to enhance tumor cell killing while minimizing damage to healthy tissues. Also serves as a reference standard in immunoassay development and preclinical research for evaluating AMHR2-targeting therapeutics.